Prisma Health - Greenville Health System - Infectious Disease — Greenville, South Carolina

Prisma Health - Greenville Health System - Infectious Disease is a clinical research site located in Greenville, South Carolina, United States 29605.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Prisma Health - Greenville Health System - Infectious Disease has participated in 1 clinical trials.

Therapeutic areas: Staphylococcal Bacteraemia.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Greenville

Browse all research sites in South Carolina · View every site in Greenville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Prisma Health - Greenville Health System - Infectious Disease?

Prisma Health - Greenville Health System - Infectious Disease has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Prisma Health - Greenville Health System - Infectious Disease conducted?

Prisma Health - Greenville Health System - Infectious Disease has 1 clinical trials on record. Their work covers Staphylococcal Bacteraemia.

Is Prisma Health - Greenville Health System - Infectious Disease accredited by Crixeo Clinical Trials?

Prisma Health - Greenville Health System - Infectious Disease has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Prisma Health - Greenville Health System - Infectious Disease?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.